header advert
Results 1 - 3 of 3
Results per page:
The Bone & Joint Journal
Vol. 105-B, Issue 6 | Pages 602 - 609
1 Jun 2023
Mistry D Ahmed U Aujla R Aslam N D’Alessandro P Malik S

Aims

In the UK, the agricultural, military, and construction sectors have stringent rules about the use of hearing protection due to the risk of noise-induced hearing loss. Orthopaedic staff may also be at risk due to the use of power tools. The UK Health and Safety Executive (HSE) have clear standards as to what are deemed acceptable occupational levels of noise on A-weighted and C-weighted scales. The aims of this review were to assess the current evidence on the testing of exposure to noise in orthopaedic operating theatres to see if it exceeds these regulations.

Methods

A search of PubMed and EMBASE databases was conducted using PRISMA guidelines. The review was registered prospectively in PROSPERO. Studies which assessed the exposure to noise for orthopaedic staff in operating theatres were included. Data about the exposure to noise were extracted from these studies and compared with the A-weighted and C-weighted acceptable levels described in the HSE regulations.


Bone & Joint Open
Vol. 1, Issue 8 | Pages 443 - 449
1 Aug 2020
Narula S Lawless A D’Alessandro P Jones CW Yates P Seymour H

Aims

A proximal femur fracture (PFF) is a common orthopaedic presentation, with an incidence of over 25,000 cases reported in the Australian and New Zealand Hip Fracture Registry (ANZHFR) in 2018. Hip fractures are known to have high mortality. The purpose of this study was to determine the utility of the Clinical Frailty Scale (CFS) in predicting 30-day and one-year mortality after a PFF in older patients.

Methods

A retrospective review of all fragility hip fractures who met the inclusion/exclusion criteria of the ANZHFR between 2017 and 2018 was undertaken at a single large volume tertiary hospital. There were 509 patients included in the study with one-year follow-up obtained in 502 cases. The CFS was applied retrospectively to patients according to their documented pre-morbid function and patients were stratified into five groups according to their frailty score. The groups were compared using t-test, analysis of variance (ANOVA), and the chi-squared test. The discriminative ability of the CFS to predict mortality was then compared with American Society of Anaesthesiologists (ASA) classification and the patient’s chronological age.


Orthopaedic Proceedings
Vol. 92-B, Issue SUPP_I | Pages 192 - 192
1 Mar 2010
D’Alessandro P Wood D Prosser G Carey-Smith R Nivbrant B Lloyd D
Full Access

Introduction: Treatment of dual compartment osteoarthritis remains controversial, with conjecture over whether Uni-Compartmental (‘UKA’) or Total Knee Arthroplasty (‘TKA’) is more appropriate for patients with patello-femoral disease. The ‘Journey Deuce’ 2/3 Knee Arthroplasty (‘2/3 Knee’) (Smith & Nephew) is a bi-cruciate retaining prosthesis designed to treat this subgroup of patients with both antero-medial and patello-femoral disease.

We have conducted a prospective, observational clinical trial of 34 patients with dual compartment osteoarthritis of the knee treated with a 2/3 Knee.

Aims: To assess the safety and clinical efficacy outcomes of the 2/3 Knee.

Method: All patients pre-op leg alignment films, as well as MRI or arthroscopy to confirm the inclusion criteria of dual compartment osteoarthritis with a preserved lateral compartment and intact cruciate ligaments. All operations were performed by a single surgeon (DW) using computer assisted surgery (CAS) and a minimally invasive technique (MIS) at a local university affiliated private hospital (HPH).

Exclusion criteria included obesity, inflammatory arthritis and a fixed flexion deformity > 10 degrees.

Subjective outcome measures included Oxford Knee Scores (OKS) and EQ-5D Scores. RSA beads were implanted at surgery to detect loosening, micro-motion and prosthesis wear. Gait analysis was conducted at 1 year post op in a subgroup of patients.

Results: Follow up ranged from 6 months to 2 years. There have been no early failures requiring complete revision. The first 23 knees (18 patients) did not have primary resurfacing of the patella. Some of these patients suffered palpable and audible patello-femoral crepitus, with a subgroup (17%, 4 knees-3 patients) having associated anterior knee pain. This subgroup had revision procedures to resurface their patellae with resolution of their symptoms. All subsequent patients have had primary patella resurfacing with no incidence of Significant crepitus or anterior knee pain.

The patients have recorded Significant improvement in their Oxford Knee Scores at 6 months (mean reduction all patients: 17.3, resurfaced 20).

Early RSA results have not detected Significant migration to indicate early loosening. Gait analysis has shown that patients return to approximate normal rather than pre-operative gait.

Conclusions: Although longer follow up is required the 2/3 Knee appears a safe and effective treatment option for patients with dual-compartment osteoarthritis; with rehabilitation, function and gait tending towards that seen in UKA rather than TKA.

It is essential that patients undergo primary patella resurfacing to prevent crepitus and associated anterior knee pain.

A study comparing clinical outcomes of 2/3 Knee vs TKA is underway at our institution.